@article{APS3537,
author = {Zheng-hong QIN and Jin WANG and Zhen-lun GU},
title = {Development of novel therapies for Huntington’s disease: hope and challenge},
journal = {Acta Pharmacologica Sinica},
volume = {26},
number = {2},
year = {2016},
keywords = {},
abstract = {Huntington’s disease (HD) is an autosomal dominant neurological disease. It is a
fatal neurological disorder affecting 5–10 out of 10 000 people. While there are
intensive research efforts focusing on uncovering molecular mechanisms of the
pathogenesis of HD, a number of studies have begun to look for effective therapies
for HD. There is a large body of encouraging news on novel therapeutic
developments. The present paper reviews drugs used for symptomatic treatment
of HD and experimental therapies targeting HD molecular pathology.},
issn = {1745-7254}, url = {http://www.chinaphar.com/article/view/3537}
}